These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2716402)

  • 1. [Enterobacter cloacae infection and marked hypophosphatemia in a patient on hemodialysis].
    Almirall J; Ponz E; Montoliu J; Revert L
    Med Clin (Barc); 1989 Feb; 92(4):158-9. PubMed ID: 2716402
    [No Abstract]   [Full Text] [Related]  

  • 2. Enterobacter cloacae graft infection/bacteremia in a hemodialysis patient.
    Cunha BA; Theodoris AC; Yannelli B
    Am J Infect Control; 2000 Apr; 28(2):181-3. PubMed ID: 10760226
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibiotic penetration in liver infection: a case of tobramycin failure responsive to moxalactam.
    Schentag JJ; Heller AS; Hardy BG; Wels PB
    Am J Gastroenterol; 1983 Oct; 78(10):641-4. PubMed ID: 6624739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the efficacy of cefotaxime alone and the combination cefazolin-tobramycin in the treatment of enterobacterial septicemia].
    Arich C; Gouby A; Bengler C; Ardilouze JL; Dubois A; Joubert P; Hansel S; Janbon C; Fabre S
    Pathol Biol (Paris); 1987 May; 35(5):613-5. PubMed ID: 3302868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enterobacter cloacae: bacteremia, epidemiology, and antibiotic resistance.
    John JF; Sharbaugh RJ; Bannister ER
    Rev Infect Dis; 1982; 4(1):13-28. PubMed ID: 7071456
    [No Abstract]   [Full Text] [Related]  

  • 6. Enterobacter meningitis--treatment complicated by emergence of mutants resistant to cefotaxime.
    Ralph ED; Behme RJ
    Scand J Infect Dis; 1987; 19(5):577-9. PubMed ID: 3423747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of cefotaxime-resistant Enterobacter during therapy of cardiac surgery patients.
    Weinstein RA
    Chemioterapia; 1985 Feb; 4(1):110-2. PubMed ID: 3986939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spondylodiscitis caused by Enterobacter cloacae treated with cefixime].
    Chassagne P; Mejjad O; Daragon A; Lecomte R; Le Loet X; Deshayes P
    Presse Med; 1990 Apr; 19(14):673-4. PubMed ID: 2139954
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nosocomial infections with resistant Enterobacter cloacae. Effects on the disease and the treatment].
    Olafsen K; Hotvedt R; Andersen BM; Almdahl SM; Sørlie D
    Tidsskr Nor Laegeforen; 1989 Jan; 109(3):332-6. PubMed ID: 2916217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of cefotaxime resistance during treatment].
    Søgaard P
    Ugeskr Laeger; 1986 Jan; 148(5):260-1. PubMed ID: 3952856
    [No Abstract]   [Full Text] [Related]  

  • 11. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Oh MD; Kim EC; Choe KW
    Clin Infect Dis; 2004 Sep; 39(6):812-8. PubMed ID: 15472813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective analysis of bacteremia because of Enterobacter cloacae compared with Escherichia coli bacteremia.
    Juanjuan D; Zhiyong Z; Xiaoju L; Yali X; Xihai Z; Zhenzhen L
    Int J Clin Pract; 2007 Apr; 61(4):583-8. PubMed ID: 17394432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical manifestation and drug sensitive tests of lower respiratory tract infection by enterobacter cloacae. The Pulmonary Infection and Fibrosis Group, Thoracic Society Shanghai Medical Association].
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Aug; 20(4):208-11. PubMed ID: 10072803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae.
    Muller A; Lopez-Lozano JM; Bertrand X; Talon D
    J Antimicrob Chemother; 2004 Jul; 54(1):173-7. PubMed ID: 15150164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of early infective endocarditis and mediastinitis in a heart transplant recipient.
    Toporoff B; Rosado LJ; Appleton CP; Sethi GK; Copeland JG
    J Heart Lung Transplant; 1994; 13(3):546-8. PubMed ID: 8061034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta-lactam resistance in aquatic Enterobacter cloacae strains using phenotypic and genotypic criteria].
    Lazăr V; Cernat R; Balotescu C; Cotar A; Coipan E; Cojocaru C
    Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):185-91. PubMed ID: 15085610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of cefotaxime at various dosage levels in urinary tract infections (author's transl)].
    Guibert J; Acar JF; Justin C; Kitzis MD
    Nouv Presse Med; 1981 Feb; 10(8):625-7. PubMed ID: 6259607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colistin in combination with rifampin and imipenem for treating a blaVIM-1 metallo-beta-lactamase-producing Enterobacter cloacae disseminated infection in a liver transplant patient.
    Tascini C; Urbani L; Biancofiore G; Rossolini GM; Leonildi A; Gemignani G; Bindi ML; Mugnaioli C; Filipponi F; Menichetti F
    Minerva Anestesiol; 2008; 74(1-2):47-9. PubMed ID: 18059255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enterobacter cloacae bloodstream infections associated with contaminated prefilled saline syringes--California, November 1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Nov; 47(44):959-60. PubMed ID: 9867522
    [No Abstract]   [Full Text] [Related]  

  • 20. [Epidemiological study of a multiresistant Enterobacter cloacae causing iatrogenic infection in a surgical unit].
    Baumgartner A; Schifferli D; Spiess B
    Zentralbl Veterinarmed B; 1984 Feb; 31(1):73-7. PubMed ID: 6720166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.